Whole-mount immunostaining confirmed that protein expression for the pan-EEC marker, CHGA, was reduced (p < 0.05) with 80 ± 2% after treatment with 1 mM SCFAs at day 4 of differentiation in enteroids from patients with obesity (Figure 5D). The gene discussed is CHGA; the disease is obesity disorder.